| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 125.12B | 124.76B | 119.82B | 122.00B | 121.93B | 138.49B |
| Gross Profit | 25.98B | 25.22B | 22.36B | 21.31B | 25.66B | 22.22B |
| EBITDA | 14.04B | 19.54B | 10.80B | 8.87B | 14.18B | 13.52B |
| Net Income | 11.26B | 10.29B | 3.66B | 2.01B | 6.17B | 6.34B |
Balance Sheet | ||||||
| Total Assets | 196.87B | 196.78B | 194.85B | 192.76B | 196.71B | 197.72B |
| Cash, Cash Equivalents and Short-Term Investments | 22.45B | 24.25B | 23.58B | 24.76B | 26.35B | 36.65B |
| Total Debt | 20.83B | 21.04B | 25.28B | 31.00B | 32.91B | 42.70B |
| Total Liabilities | 67.55B | 66.28B | 75.68B | 78.46B | 86.22B | 94.05B |
| Stockholders Equity | 127.00B | 128.01B | 116.75B | 112.06B | 108.45B | 101.90B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.27B | 4.48B | -2.24B | -252.00M | 4.26B |
| Operating Cash Flow | 0.00 | 4.17B | 9.02B | 3.00B | 7.58B | 11.52B |
| Investing Cash Flow | 0.00 | 1.42B | -1.45B | -2.19B | -6.64B | -3.77B |
| Financing Cash Flow | 0.00 | -7.00B | -10.21B | -3.84B | -11.42B | -358.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥114.27B | 10.07 | ― | 3.72% | 5.40% | 14.80% | |
76 Outperform | ¥81.09B | 6.04 | ― | 3.04% | 1.57% | -33.97% | |
74 Outperform | ¥36.60B | 15.61 | ― | 3.70% | 14.83% | 51.42% | |
71 Outperform | ¥20.25B | 4.28 | ― | 3.61% | 8.85% | 110.05% | |
70 Outperform | ¥57.47B | -468.17 | ― | 4.37% | -1.09% | ― | |
66 Neutral | ¥8.16B | 2.66 | ― | 2.84% | 37.67% | -117.29% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |